Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 192
8
Diseases
18
Unique genes
0.199
Avg. similarity score
Cinca syndrome
Most-connected disease (5 links)
Disease
Searched: Cinca syndrome
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Cinca syndrome
Infantile neurological cutaneous and articular syndrome
Cold autoinflammatory syndrome
Cryopyrin-associated periodic syndrome
Autosomal dominant sensorineural deafness
Anaphylaxis
Autoinflammation, antibody deficiency, and immune dysregulation
Hearing loss with hypertrophic cardiomyopathy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Cinca syndrome | 5 | 5 | 1 |
| Infantile neurological cutaneous and articular syndrome | 5 | 5 | 1 |
| Cold autoinflammatory syndrome | 4 | 4 | 6 |
| Cryopyrin-associated periodic syndrome | 4 | 4 | 4 |
| Autosomal dominant sensorineural deafness | 3 | 3 | 6 |
| Anaphylaxis | 2 | 2 | 7 |
| Autoinflammation, antibody deficiency, and immune dysregulation | 2 | 2 | 1 |
| Hearing loss with hypertrophic cardiomyopathy | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| NLRP3 | 6 / 8 | Anaphylaxis, Autosomal dominant sensorineural deafness, Cinca syndrome, Cold autoinflammatory syndrome and 2 more |
| PLCG2 | 3 / 8 | Autoinflammation, antibody deficiency, and immune dysregulation, Cold autoinflammatory syndrome, Cryopyrin-associated periodic syndrome |
| MYO6 | 2 / 8 | Autosomal dominant sensorineural deafness, Hearing loss with hypertrophic cardiomyopathy |
| NLRC4 | 2 / 8 | Cold autoinflammatory syndrome, Cryopyrin-associated periodic syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Intrinsic Pathway of Fibrin Clot Formation | Reactome | 2 / 23 | 58.0× | 5.27e-4 | 8.61e-3 ✓ sig. |
| G alpha (q) signalling events | Reactome | 3 / 172 | 11.6× | 2.01e-3 | 2.37e-2 ✓ sig. |
| NOD-like receptor signaling pathway | KEGG | 3 / 187 | 10.7× | 2.55e-3 | 2.82e-2 ✓ sig. |
| The IPAF inflammasome | Reactome | 1 / 2 | 334× | 3.00e-3 | 3.15e-2 ✓ sig. |
| Pathogenic Escherichia coli infection | KEGG | 3 / 200 | 10.0× | 3.09e-3 | 3.21e-2 ✓ sig. |
| Salmonella infection | KEGG | 3 / 248 | 8.1× | 5.64e-3 | 4.92e-2 ✓ sig. |
| Glioma | KEGG | 2 / 76 | 17.6× | 5.66e-3 | 4.92e-2 ✓ sig. |
| Shigellosis | KEGG | 3 / 250 | 8.0× | 5.77e-3 | 4.99e-2 ✓ sig. |
| Leukotriene receptors | Reactome | 1 / 5 | 133× | 7.47e-3 | 5.89e-2 |
| Complement and coagulation cascades | KEGG | 2 / 88 | 15.2× | 7.53e-3 | 5.91e-2 |
| Fc gamma R-mediated phagocytosis | KEGG | 2 / 98 | 13.6× | 9.26e-3 | 6.77e-2 |
| Inflammatory mediator regulation of TRP channels | KEGG | 2 / 99 | 13.5× | 9.44e-3 | 6.85e-2 |
| C-type lectin receptor signaling pathway | KEGG | 2 / 105 | 12.7× | 1.06e-2 | 7.35e-2 |
| CD163 mediating an anti-inflammatory response | Reactome | 1 / 9 | 74.1× | 1.34e-2 | 8.46e-2 |
| DCC mediated attractive signaling | Reactome | 1 / 11 | 60.7× | 1.64e-2 | 9.53e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of interleukin-1 beta production | GO:0032731 | 3 / 66 | 47.2× | 3.31e-5 | 1.36e-3 ✓ sig. |
| inflammatory response | GO:0006954 | 5 / 467 | 11.1× | 6.24e-5 | 2.20e-3 ✓ sig. |
| actin filament-based movement | GO:0030048 | 2 / 21 | 98.9× | 1.82e-4 | 4.89e-3 ✓ sig. |
| pattern recognition receptor signaling pathway | GO:0002221 | 2 / 21 | 98.9× | 1.82e-4 | 4.89e-3 ✓ sig. |
| positive regulation of inflammatory response | GO:0050729 | 3 / 122 | 25.5× | 2.06e-4 | 5.33e-3 ✓ sig. |
| positive regulation of apoptotic process | GO:0043065 | 4 / 326 | 12.7× | 2.29e-4 | 5.74e-3 ✓ sig. |
| positive regulation of NLRP3 inflammasome complex assembly | GO:1900227 | 2 / 33 | 62.9× | 4.55e-4 | 9.28e-3 ✓ sig. |
| regulation of canonical NF-kappaB signal transduction | GO:0043122 | 2 / 36 | 57.7× | 5.41e-4 | 1.04e-2 ✓ sig. |
| pyroptotic inflammatory response | GO:0070269 | 2 / 40 | 51.9× | 6.69e-4 | 1.20e-2 ✓ sig. |
| negative regulation of non-canonical NF-kappaB signal transduction | GO:1901223 | 2 / 41 | 50.6× | 7.03e-4 | 1.24e-2 ✓ sig. |
| negative regulation of ventricular cardiac muscle cell action potential | GO:1903946 | 1 / 1 | 1,038× | 9.63e-4 | 1.52e-2 ✓ sig. |
| regulation of granulocyte chemotaxis | GO:0071622 | 1 / 1 | 1,038× | 9.63e-4 | 1.52e-2 ✓ sig. |
| placenta development | GO:0001890 | 2 / 48 | 43.3× | 9.63e-4 | 1.52e-2 ✓ sig. |
| neuropeptide processing | GO:0061837 | 1 / 1 | 1,038× | 9.63e-4 | 1.52e-2 ✓ sig. |
| regulation of interleukin-18 production | GO:0032661 | 1 / 1 | 1,038× | 9.63e-4 | 1.52e-2 ✓ sig. |